The development of a visually significant cataract in a patient with glaucoma is a common and often expected event. The decisionmaking process regarding the timing and type of surgery offered for a patient with a visually significant cataract and glaucoma is complex, and depends on factors such as vision, visual potential, intraocular pressure (IOP) control, medication use and tolerance, optic nerve damage, visual field loss and the aetiology of the patient's glaucoma. In addition, failure of a newer surgery to obtain a desired IOP often does not limit the successful implementation of a traditional surgery.
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Glaucoma Surgery and/or erosion of the conjunctiva over the tube or plate. 6, 7 As previously mentioned, the decision to perform incisional glaucoma surgery requires the consideration of multiple factors. In general, many of the newer surgical techniques are indicated for the same types of patient who traditionally would have been considered candidates for selective laser trabeculoplasty (SLT) or trabeculectomy.
Due to their low rate of serious complications and limited destruction or manipulation of ocular tissue (especially the conjunctiva), many of the newer surgeries, such as Trabectome or ECP, are considered earlier in the course of treatment than traditional glaucoma surgeries.
In addition, failure of a newer surgery to obtain a desired IOP often does not limit the successful implementation of a traditional surgery.
ExPRESS Shunt
The Like the traditional trabeculectomy, a bleb is still created; however, an iridectomy is not necessary. canaloplasty is a non-penetrating procedure. 12 A final advantage of canaloplasty is that there are no flap sutures to remove and no bleb formation to modulate, so post-operative management often requires fewer visits than trabeculectomy patients. 15 One major disadvantage of canaloplasty is that it is a technically complex surgery, requiring techniques and dissections that many surgeons may not be comfortable performing. In addition, canaloplasty requires a significant amount of conjunctival dissection, which may limit the execution of subsequent traditional glaucoma surgeries. Finally, as mentioned before, successful canaloplasty typically results in IOPs in the mid-teens, which may not be low enough for some patients.
Trabectome
The Trabectome (NeoMedix Corp., Tustin, CA, US) is a novel method for performing an ab interno goniotomy (see Figure 3A) , lowering IOP by improving aqueous access to Schlemm's canal outflow channels.
Unlike traditional incisional goniotomy or trabeculotomy, the Trabectome system uses electrocautery to ablate an area of the trabecular meshwork and the inner wall of Schlemm's canal. The handheld Trabectome instrument (see Figure 3B ) is inserted into the anterior chamber through a clear corneal incision and enters 
Endoscopic Cyclophotocoagulation
While the devices and surgical techniques discussed above focus on improved outflow methods, ECP (Endo Optiks, Little Silver, NJ, US) decreases aqueous production by ablating ciliary body tissue.
Cyclodestruction has historically been performed trans-sclerally and was reserved for refractory cases of glaucoma or for eyes with limited visual potential. ECP allows for direct visualisation and photocoagulation of the ciliary body. The advantage of ECP over transscleral cyclophotocoagulation is that more directed photocoagulation spares collateral damage to adjacent ocular structures.
ECP utilises a diode laser that emits pulsed continuous-wave energy at 810nm from a 175W xenon light source combined with a heliumneon laser aiming beam and video camera imaging (see Figure 4A ).
These components are transmitted by a 18-or 20-gauge fibre optic connected probe (see Figure 4B ) that is inserted intraocularly via the anterior chamber, or occasionally through the pars plana. Typically, 180-270º of the pars plicata is treated. ECP can be performed during cataract surgery, after removal of the crystalline lens and prior to placement of the IOL in pseudophakic eyes, and rarely in phakic eyes.
Glaucoma Surgery Note the collector channels exposed after the trabecular meshwork is ablated.
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ECP is generally indicated for patients not well controlled on topical IOP-lowering therapy or in well-controlled glaucoma patients with a visually significant cataract who would like to reduce the number of IOP-lowering medications required. Extensive ECP treating the pars plicata and pars plana may also be useful for recalcitrant glaucomas, such as in patients with failed tube shunts. 18 The endoscope of the ECP can also be a useful tool to visualise intraocular structures when corneal or anterior segment pathology limits the surgeon's view posteriorly.
Studies have supported the use of combined ECP/phacoemulsification procedures to decrease IOP and the number of IOP-lowering medications after surgery. One report with 125 eyes showed a 16% IOP reduction at five years, with 76% of treated eyes requiring one or fewer medications and 61% of eyes requiring no medications. 19 Additional studies have supported these claims and also show no differences in the incidence of angiographic CME between eyes undergoing ECP/phacoemulsification and phacoemulsification alone. 20, 21 A disadvantage of ECP is that it involves the photocoagulation or destruction of an important intraocular tissue. Occasionally, ECP can result in significant uveitis, and there is some concern regarding the long-term effect of decreasing aqueous production on intraocular tissues such as the corneal endothelium.
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